Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quest Pharmatech Inc
V.QPT
Alternate Symbol(s):
QPTFF
Healthcare
Biotechnology
Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy...
products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:QPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(94)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 06, 2023 3:40pm
RE:Interesting
ARIMAII, where are you getting this information from? G1945V
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 06, 2023 2:05pm
RE:Interesting
Maybe QPT gave in regarding coming to a short resolution with this but getting 10-20% of that amount would show the market QPT is able and capable of monetizing this deal. Hard to phatom: stage
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jan 06, 2023 12:34pm
Interesting
https://ceo.ca/qpt?032621d78bb4 (Q3 MD&A) QPT has $80M worth of bonds (Fair Value). Since OQP Bio is a private company, with limited liquidity, Quest is negotiating to exchange the OQP
...more
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Dec 02, 2022 6:08pm
RE:RE:.055
https://www.flora-5.com/Home.aspx https://clinicaltrials.gov/ct2/history/NCT04498117?V_78=View#StudyPageTop
(94)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Nov 30, 2022 8:52am
RE:.055
It would seem that our CEO is not protecting shareholders' interests. I'm not sure that he knows what's going on. But he is sure looking after his self-interest. jmo G1945V
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Post by
bigstar10
on Nov 29, 2022 4:12pm
.055
Sinking.....wow
(94)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 29, 2022 7:47am
RE:New Press Release - Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology License
To me, it looks like more disassembling of QPT's equity investments taking place by our leader. First OncoQuest, for $300Mil (ya) where that lands no one knows. He even had to borrow $1 Mil for
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 28, 2022 5:00pm
New Press Release - Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology License
EDMONTON, AB, Sept. 28, 2022 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the sale of its share ownership interest in Bioceltran Co., Ltd. ("Bioceltran") to Dr. Sang Ho Jang, founder of Bioceltran, for sale proceeds of $300,0000 and the termination and...
read article.
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Sep 23, 2022 2:20pm
Summary
https://www.rally-co.ca/post/qpt-v-upside
(94)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 17, 2022 10:31am
RE:Interesting
NICE of Niraparib: https://www.nice.org.uk/guidance/indevelopment/gid-ta10635 G1945V
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Sep 16, 2022 2:32pm
Interesting
https://ceo.ca/qpt?067dc4a11230
(94)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 13, 2022 8:48am
RE:RE:RE:RE:RE:RE:Hmm...
By now you would think that our CEO (Madi R. Madiyalakan) would step up to the plate to reassure us that all is well and that the deal OncoQuest made is still on track, seeing that he is the CEO of
...more
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Sep 09, 2022 11:37am
RE:RE:RE:RE:RE:Hmm...
(Google Translated) from Canaria Bio (Two items) 1. https://canariabio.com/ir/notice/?uid=86&mod=document&pageid=1 Notice to shareholders and stakeholders Posted bycanariabioPosted on
...more
(3)
•••
PosNeg1
X
View Profile
View Bullboard History
Comment by
PosNeg1
on Aug 17, 2022 4:39pm
RE:RE:RE:RE:Hmm...
10 Yrs is a joke, $ due from Korea by end of August. Lets see what happens
(30)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jul 22, 2022 5:31pm
RE:RE:RE:Hmm...
https://ceo.ca/@newswire/quest-pharmatech-announces-results-from-agm-99616 On a corporate matter, Quest announces the granting of 1,300,000 stock options to Directors and Officers, all at a volume
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >